MoneyWorks4Me

Senores Pharmaceuticals informs about press release

24 Jan 2025 Evaluate
Senores Pharmaceuticals has informed that it enclosed copies of Newspaper Publications of the extracts of Consolidated and Standalone Un-audited Financial Results of the Company for quarter and nine months ended December 31, 2024, as published, in Financial Express -English and Gujarati Edition, on January 24, 2025. This intimation is also being uploaded on the website of the Company, www.senorespharma.com.

The above information is a part of company’s filings submitted to BSE.

Senores Pharmaceutic Share Price

1427.10 -5.35 (-0.37%)
04-Sep-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1899.00
Dr. Reddys Labs. 1154.00
Cipla 1385.00
Lupin 2111.00
Zydus Lifesciences 1121.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: